Synaptogenix (SNPX) Competitors $2.60 -0.05 (-1.89%) (As of 09:30 AM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestTrends SNPX vs. PMCB, AIM, SLGL, NLSP, WENA, SNSE, NKGN, AWH, TLPH, and TSBXShould you be buying Synaptogenix stock or one of its competitors? The main competitors of Synaptogenix include PharmaCyte Biotech (PMCB), AIM ImmunoTech (AIM), Sol-Gel Technologies (SLGL), NLS Pharmaceutics (NLSP), ANEW Medical (WENA), Sensei Biotherapeutics (SNSE), NKGen Biotech (NKGN), Aspira Women's Health (AWH), Talphera (TLPH), and Turnstone Biologics (TSBX). These companies are all part of the "pharmaceutical products" industry. Synaptogenix vs. PharmaCyte Biotech AIM ImmunoTech Sol-Gel Technologies NLS Pharmaceutics ANEW Medical Sensei Biotherapeutics NKGen Biotech Aspira Women's Health Talphera Turnstone Biologics Synaptogenix (NASDAQ:SNPX) and PharmaCyte Biotech (NASDAQ:PMCB) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their valuation, institutional ownership, profitability, community ranking, earnings, media sentiment, dividends, risk and analyst recommendations. Do institutionals & insiders hold more shares of SNPX or PMCB? 10.3% of Synaptogenix shares are owned by institutional investors. Comparatively, 34.2% of PharmaCyte Biotech shares are owned by institutional investors. 2.7% of Synaptogenix shares are owned by company insiders. Comparatively, 1.0% of PharmaCyte Biotech shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Do analysts rate SNPX or PMCB? Synaptogenix currently has a consensus target price of $14.00, indicating a potential upside of 438.46%. Given Synaptogenix's stronger consensus rating and higher probable upside, research analysts plainly believe Synaptogenix is more favorable than PharmaCyte Biotech.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Synaptogenix 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00PharmaCyte Biotech 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Which has more volatility & risk, SNPX or PMCB? Synaptogenix has a beta of 1.19, meaning that its share price is 19% more volatile than the S&P 500. Comparatively, PharmaCyte Biotech has a beta of -0.2, meaning that its share price is 120% less volatile than the S&P 500. Does the media prefer SNPX or PMCB? In the previous week, PharmaCyte Biotech's average media sentiment score of 0.00 beat Synaptogenix's score of -3.00 indicating that PharmaCyte Biotech is being referred to more favorably in the news media. Company Overall Sentiment Synaptogenix Very Negative PharmaCyte Biotech Neutral Which has better valuation & earnings, SNPX or PMCB? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSynaptogenixN/AN/A-$6.04MN/AN/APharmaCyte BiotechN/AN/A$330K$0.662.71 Is SNPX or PMCB more profitable? PharmaCyte Biotech's return on equity of 1.38% beat Synaptogenix's return on equity.Company Net Margins Return on Equity Return on Assets SynaptogenixN/A -42.14% -29.42% PharmaCyte Biotech N/A 1.38%0.71% Does the MarketBeat Community prefer SNPX or PMCB? Synaptogenix received 2 more outperform votes than PharmaCyte Biotech when rated by MarketBeat users. CompanyUnderperformOutperformSynaptogenixOutperform Votes266.67% Underperform Votes133.33% PharmaCyte BiotechN/AN/A SummarySynaptogenix beats PharmaCyte Biotech on 6 of the 11 factors compared between the two stocks. Ad Weiss RatingsTrump won. Buy this coin now.Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will go to $150,000 — or more. But there’s one coin he thinks could go even higher.This could be his favorite coin. Get Synaptogenix News Delivered to You Automatically Sign up to receive the latest news and ratings for SNPX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SNPX vs. The Competition Export to ExcelMetricSynaptogenixPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$3.54M$6.53B$5.10B$8.84BDividend YieldN/A8.11%5.04%4.07%P/E RatioN/A5.5095.1214.22Price / SalesN/A375.021,217.3088.42Price / CashN/A52.5939.4936.27Price / Book0.2810.276.976.37Net Income-$6.04M$153.22M$118.73M$225.56M7 Day Performance-0.38%-1.19%-1.22%-0.02%1 Month Performance-27.78%-6.71%-3.07%2.04%1 Year Performance-60.90%32.39%32.52%28.00% Synaptogenix Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SNPXSynaptogenix2.0975 of 5 stars$2.60-1.9%$14.00+438.5%-59.2%$3.54MN/A0.004Negative NewsPMCBPharmaCyte Biotech0.6454 of 5 stars$1.79+4.1%N/A-21.1%$13.75MN/A2.612AIMAIM ImmunoTech1.7374 of 5 stars$0.21+5.4%$3.00+1,323.8%-52.0%$13.42M$200,000.00-0.4520News CoverageSLGLSol-Gel Technologies3.6128 of 5 stars$0.48+8.3%$5.00+947.1%-68.5%$13.30M$1.55M-1.3050News CoverageGap DownNLSPNLS Pharmaceutics1.2189 of 5 stars$3.34+1.5%N/A+623.1%$12.76MN/A0.006WENAANEW MedicalN/A$0.73-0.5%N/AN/A$12.51MN/A0.00N/AGap UpSNSESensei Biotherapeutics4.8056 of 5 stars$0.48-2.8%$4.33+795.5%-20.0%$12.17MN/A0.0040News CoverageNKGNNKGen BiotechN/A$0.34+7.9%N/A-89.1%$11.94M$80,000.00-0.06N/AGap UpHigh Trading VolumeAWHAspira Women's Health1.6792 of 5 stars$0.74+1.4%$4.40+494.6%-78.5%$11.88M$9.15M-0.64110Analyst ForecastTLPHTalphera2.6915 of 5 stars$0.69-1.9%$4.50+549.3%N/A$11.80M$650,000.000.0019Gap UpTSBXTurnstone Biologics3.2023 of 5 stars$0.48+4.4%$2.13+342.7%-84.8%$11.10M$19.31M0.0082 Related Companies and Tools Related Companies PharmaCyte Biotech Alternatives AIM ImmunoTech Alternatives Sol-Gel Technologies Alternatives NLS Pharmaceutics Alternatives ANEW Medical Alternatives Sensei Biotherapeutics Alternatives NKGen Biotech Alternatives Aspira Women's Health Alternatives Talphera Alternatives Turnstone Biologics Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:SNPX) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Synaptogenix, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Synaptogenix With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SNPX Stock Alerts